scispace - formally typeset
Journal ArticleDOI

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008

TLDR
EFSUMB study group M. Claudon, D. Cosgrove, T. Tranquart, L. Thorelius, and H. Whittingham study group L. de.
Abstract
EFSUMB study group M. Claudon1, D. Cosgrove2, T. Albrecht3, L. Bolondi4, M. Bosio5, F. Calliada6, J.-M. Correas7, K. Darge8, C. Dietrich9, M. D'On ofrio10, D. H. Evans11, C. Filice12, L. Greiner13, K. Jäger14, N. de. Jong15, E. Leen16, R. Lencioni17, D. Lindsell18, A. Martegani19, S. Meairs20, C. Nolsøe21, F. Piscaglia22, P. Ricci23, G. Seidel24, B. Skjoldbye25, L. Solbiati26, L. Thorelius27, F. Tranquart28, H. P. Weskott29, T. Whittingham30

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.

TL;DR: DCE-US with quantitative analysis has the potential to make preoperative differential diagnosis between focal-type AIP and PDAC non-invasively.
Book ChapterDOI

Overview of Functional MR, CT, and US Imaging Techniques in Clinical Use

TL;DR: This chapter describes the leading functional imaging strategies, i.e., vascular imaging methods, which include the dynamic contrast-enhanced MRI, perfusion CT, and contrast- Enhanced ultrasonography, as well as methods that probe tumor cellularity and metabolism,i.e, diffusion-weighted MRI and magnetic resonance spectroscopy, respectively.
Journal ArticleDOI

Portal vein thrombosis with contrast-enhanced ultrasound in a patient with hepatocellular carcinoma: a case study.

TL;DR: The use of contrast‐enhanced ultrasound used as a non‐invasive method to define the bland and malignant components of portal vein thrombosis in a 76‐year‐old male with hepatocellular carcinoma and cirrhosis is described.
References
More filters
Journal ArticleDOI

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

TL;DR: A model by which a combined assessment of all existing lesions, characterized by target lesions and nontarget lesions, is used to extrapolate an overall response to treatment is proposed, which is largely validated by the Response Evaluation Criteria in Solid Tumors Group and integrated into the present guidelines.
Journal ArticleDOI

Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.

TL;DR: RF ablation is an effective method to treat hepatic metastases from colorectal carcinoma and Frequency and time to local recurrence were related to lesion size (P < or =.001).
Journal ArticleDOI

Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions

TL;DR: RF ablation appears to be an effective, safe, and relatively simple procedure for the treatment of medium and large HCCs in patients with cirrhosis or chronic hepatitis.
Journal ArticleDOI

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.

TL;DR: RF interstitial thermal ablation is a useful percutaneous treatment for hepatic cancer and in the patients treated for metastatic nodules, posttreatment imaging studies showed necrosis that varied from 80% to 100% in all cases.
Journal ArticleDOI

Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents

TL;DR: In vitro measurements comparing flowing agent and cellulose particles suggest that pulse inversion Doppler can provide 3 to 10 dB more agent to tissue contrast than harmonic imaging with similar pulses, and in vitro measurements suggest that broadband pulse inverts can provide up to 16 dB more contrast than broadband conventional Dopplers.
Related Papers (5)